PORTFOLIO

Project presentations on the website

Every project supported by Gebert Rüf Stiftung is made accessible with a web presentation that informs about the core data of the project. With this public presentation, the foundation publishes the funding results achieved and contributes to the communication of science to society.

Close

KOVE – Minimally Invasive Device to Prevent Preterm Birth

Editorial

The project management is responsible for the content of the information provided.

Cooperation

This project, funded by Gebert Rüf Stiftung, is supported by the following project partners: University of Zürich, Universitätsspital Zürich, Venture Kick, Therapy Development Accelerator Zürich, UZH Incubator lab, BRIDGE proof of concept, Innosuisse

Project data

  • Project no: GRS-068/19 
  • Amount of funding: CHF 150'000 
  • Approved: 30.10.2019 
  • Duration: 06.2020 - 02.2022 
  • Area of activity:  InnoBooster, seit 2018

Project management

Project description

Recent development in pre-natal diagnosis and therapy enable the detection and the treatment of life-threatening congenital diseases on fetuses during pregnancy. Those minimally invasive interventions in the womb, called fetoscopies, come along with a 80% risk of preterm birth related to the perforation of the fetal membrane through the insertion of the medical instruments. This important collateral effect is a critical limitation for those fetoscopies and for the development of more sophisticated fetal surgeries. Our innovative technology prevents membrane rupture following fetoscopies, which will help fighting against fetal morbidity and mortality and unleash the potential of fetoscopy.

What is special about the project?

As we speak, nothing is done to secure the hole, which is left open after the intervention. The innovative strategy developed by our lab consists of closing the defect at the site of puncture and fixing the fetal membrane to the uterus utilizing a proprietary device following a fetoscopic intervention, which would prevent iPPROM.
Fetal surgery is a treatment method that will evolve into standard of care in the next decades. The perspective of having a high failure rate due to preterm fetal membrane rupture is unimaginable. The establishment of a method to prevent this to happen appears to be a necessary step to unleash the potential of those surgical procedures. A lasting impact will depend on the efficient and fast market entry of our future start-up, which can be achieved thanks to this funding.

Status/Results

We demonstrated the feasibility of this method ex vivo and on an in vivo pregnant sheep model. The successful application of the sealing device demonstrated the long term sealing of the membrane. In addition, the device prototype was produced and its further development for industrialization is ongoing. KOVE medical AG was incorporated in November 2020 and is now raising its seed investment to reach CE/FDA approval.

Publications

Minimally Invasive Surgical Device for Precise Application of Bioadhesives to Prevent iPPROM. PMID: 29920508

Media

Links

Persons involved in the project

Yannick Devaud, project leader E-mail | Linkedin

Last update to this project presentation  14.04.2022